Cargando…

CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies

Tetraspanins are integral transmembrane proteins organized in microdomains displaying specific and direct interactions with other tetraspanins and molecular partners. Among them, CD81 has been implicated in a variety of physiological and pathological processes. CD81 also plays a crucial role in path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zona, Laetitia, Tawar, Rajiv G., Zeisel, Mirjam B., Schuster, Catherine, Lupberger, Joachim, Baumert, Thomas F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939486/ https://www.ncbi.nlm.nih.gov/pubmed/24553110 http://dx.doi.org/10.3390/v6020875

Ejemplares similares

A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission
por: Fofana, Isabel, et al.
Publicado: (2013)

Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors
por: Bitzegeio, Julia, et al.
Publicado: (2010)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015)

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes
por: Verrier, Eloi R., et al.
Publicado: (2016)

Claudin Association with CD81 Defines Hepatitis C Virus Entry
por: Harris, Helen J., et al.
Publicado: (2010)

Cholesterol sensing by CD81 is important for hepatitis C virus entry
por: Palor, Machaela, et al.
Publicado: (2020)

Host-targeting therapies for hepatitis C virus infection: current developments and future applications
por: Crouchet, Emilie, et al.
Publicado: (2018)

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection
por: Verrier, Eloi R., et al.
Publicado: (2016)

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry
por: Rocha-Perugini, Vera, et al.
Publicado: (2008)

The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry
por: Rocha-Perugini, Vera, et al.
Publicado: (2009)

Safety and Antiviral Activity of EGFR Inhibition by Erlotinib in Chronic Hepatitis C Patients: A Phase Ib Randomized Controlled Trial
por: Saviano, Antonio, et al.
Publicado: (2022)

Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C
por: Xiao, Fei, et al.
Publicado: (2015)

Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process
por: Colpitts, Che C., et al.
Publicado: (2020)

CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells
por: Banse, Pia, et al.
Publicado: (2018)

Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents
por: Xiao, Fei, et al.
Publicado: (2014)

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
por: Wrensch, Florian, et al.
Publicado: (2018)

CD81 and Hepatitis C Virus (HCV) Infection
por: Fénéant, Lucie, et al.
Publicado: (2014)

A Neutralization Epitope in the Hepatitis C Virus E2 Glycoprotein Interacts with Host Entry Factor CD81
por: Zhao, Zhong, et al.
Publicado: (2014)

Adaptive Immunity to Hepatitis C Virus
por: Zeisel, Mirjam B., et al.
Publicado: (2009)

Hepatitis C virus infection and related liver disease: the quest for the best animal model
por: Mailly, Laurent, et al.
Publicado: (2013)

Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding
por: Rothwangl, Katharina B, et al.
Publicado: (2008)

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges
por: Lupberger, Joachim, et al.
Publicado: (2021)

Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
por: Goto, Kaku, et al.
Publicado: (2020)

Genotype 1 Hepatitis C Virus Envelope Features That Determine Antiviral Response Assessed through Optimal Covariance Networks
por: Murray, John M., et al.
Publicado: (2013)

Mathematical Model of Viral Kinetics In Vitro Estimates the Number of E2-CD81 Complexes Necessary for Hepatitis C Virus Entry
por: Padmanabhan, Pranesh, et al.
Publicado: (2011)

Hepatoma polarization limits CD81 and hepatitis C virus dynamics
por: Harris, H J, et al.
Publicado: (2013)

A Role for CD81 and Hepatitis C Virus in Hepatoma Mobility
por: Brimacombe, Claire L., et al.
Publicado: (2014)

Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection
por: Fafi-Kremer, Samira, et al.
Publicado: (2012)

Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes
por: Ramanathan, Aarti, et al.
Publicado: (2016)

HIV-1 Entry and Trans-Infection of Astrocytes Involves CD81 Vesicles
por: Gray, Lachlan R., et al.
Publicado: (2014)

In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface
por: Davis, Christopher, et al.
Publicado: (2012)

PI4K-beta and MKNK1 are regulators of hepatitis C virus IRES-dependent translation
por: Lupberger, Joachim, et al.
Publicado: (2015)

Active RNA Replication of Hepatitis C Virus Downregulates CD81 Expression
por: Ke, Po-Yuan, et al.
Publicado: (2013)

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape
por: Colpitts, Che C, et al.
Publicado: (2018)

Correction: HIV-1 Entry and Trans-Infection of Astrocytes Involves CD81 Vesicles
Publicado: (2014)

Recombinant hepatitis C virus-envelope protein 2 interactions with low-density lipoprotein/CD81 receptors
por: Urbaczek, Ana Carolina, et al.
Publicado: (2015)

Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection
por: Heuschkel, Margaux J., et al.
Publicado: (2021)

Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences
por: Boulahtouf, Zakaria, et al.
Publicado: (2022)

Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets
por: Verrier, Eloi R, et al.
Publicado: (2020)

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
por: Witteveldt, Jeroen, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_54tq0t2hkt13fn7eie12m7vfgf